For Investors
Please click here for AIM Rule 26 Information
ImmuPharma plc shares have been admitted by the London Stock Exchange plc to AIM and trade under the
symbol IMM (LSE:IMM or for Bloomberg IMM:LN).Current share price information (15 mins delayed) is available from the London Stock Exchange (LSE).
Trade mark of London Stock Exchange plc
Annual Report
Financial Calendar
Financial Results announced. Please visit our News Section.
Registered Office
50 Broadway, London SW1H 0BL, UK
Registrars
Computershare Investor Services PLC, PO Box 82, The Pavilions,
Bridgewater Road, Bristol, BS99 7NH, UK
Advisers
Nominated Advisor & Broker
Panmure Gordon & Co. plc, 155 Moorgate, London EC2M 6XB, UK
Broker
Cornhill Asset Management Ltd, 1 Cornhill, London EC3V 3ND, UK
Public Relations
Lisa Baderoon, Director, Buchanan Communications, 6th Floor,
45 Moorfields, London EC2Y 9AE, UK. Tel: +44 20 7466 5000
Reporting Accountants
Nexia Audit Limited, 25 Moorgate, London EC2R 6AY, UK
Financial Advisor
Dawnay, Day Corporate Finance Limited, 17 Grosvenor Gardens, London SW1W
0BD, UK
Solicitors
Bircham Dyson Bell, 50 Broadway, London SW1H 0BL, UK
Analysts covering ImmuPharma
Sav Neophytou - Panmure Gordon & Co, 14th Floor, Unity Building, 20
Chapel Street, Liverpool L3 9AG, UK. Tel: +44 151 243 0960
Shawn Manning - Landsbanki Securities (UK) Limited, Beaufort House, 15 St. Botolph Street, London EC3A 7QR , UK. Tel: +44 7426 9000
Robin Davison / Jacob Plieth - Edison Investment Research Limited, Bracton House 34-36, London WC1V 6AE, UK. Tel: +44 20 7190 1760
Ian White - True Research Limited, Second Floor, 9 Hanover Street, London W1S 1YF, UK. Tel: +44 20 7493 8187

